Internal Medicine, Clinical Cardiatric Electrophysiology · Bowling Green, KY
NPI
1326042185
Since 2005
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
201 Park St
Bowling Green, KY, 42101
Phone (270) 781-5111
Medicare paid, 2024
$305K
9,575 services
Medicare patients, 2024
697
Average age 77
Drug cost, 2024
$2.8M
11,628 prescriptions
Company payments, 2025
$867
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles S Lin was code 99214 (office e&m - established), 1,505 times for 590 patients. In total Charles S Lin billed 9,575 services in 120 codes, and Medicare paid $305K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,505 | 590 | $84.82 | $128K |
| 93306 Echocardiography (TTE/TEE) | Office | 247 | 242 | $137.43 | $34K |
| 93296 External Electrocardiographic Monitoring | Office | 221 | 70 | $13.93 | $3,078 |
| 93294 External Electrocardiographic Monitoring | Office | 183 | 67 | $20.07 | $3,673 |
| 93015 Electrocardiogram | Office | 167 | 157 | $49.91 | $8,336 |
| 93000 Electrocardiogram | Office | 164 | 132 | $9.63 | $1,579 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 156 | 38 | $4.95 | $773 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 99 | 49 | $30.03 | $2,973 |
| 80061 Clinical Chemistry | Office | 91 | 88 | $13.12 | $1,194 |
| 82550 Clinical Chemistry | Office | 91 | 89 | $6.38 | $581 |
| 82306 Clinical Chemistry | Office | 80 | 79 | $29.01 | $2,321 |
| 93288 External Electrocardiographic Monitoring | Office | 76 | 40 | $15.47 | $1,175 |
| 93297 External Electrocardiographic Monitoring | Office | 70 | 16 | $42.35 | $2,964 |
| 93306 Echocardiography (TTE/TEE) | Facility | 70 | 70 | $51.62 | $3,613 |
| 99222 Hospital E&M - Initial | Facility | 67 | 62 | $96.04 | $6,435 |
By year: 2022 $346K for 6,772 services; 2023 $375K for 10,153 services; 2024 $305K for 9,575 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82550 Clinical Chemistry | 91 | 89 | $6.38 | $581 |
| 80061 Clinical Chemistry | 91 | 88 | $13.12 | $1,194 |
| 82306 Clinical Chemistry | 80 | 79 | $29.01 | $2,321 |
| 80076 Clinical Chemistry | 55 | 55 | $8.01 | $441 |
| 80048 Clinical Chemistry | 42 | 36 | $8.29 | $348 |
| 80053 Clinical Chemistry | 41 | 40 | $10.35 | $424 |
| 83036 Blood Count | 35 | 34 | $9.52 | $333 |
| 83880 Clinical Chemistry | 28 | 27 | $38.47 | $1,077 |
| 85025 Blood Count | 26 | 24 | $7.61 | $198 |
| 83721 Clinical Chemistry | 15 | 14 | $10.29 | $154 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles S Lin prescribed most often to Medicare patients was Metoprolol Succinate, with 1,077 prescriptions and refills. In total Charles S Lin wrote 11,628 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,077 | 1,946 | 214 | $12K |
| Atorvastatin Calcium Generic | 1,035 | 2,104 | 231 | $6,795 |
| Eliquis Apixaban | 801 | 1,234 | 153 | $691K |
| Entresto Sacubitril/Valsartan | 654 | 959 | 113 | $610K |
| Farxiga Dapagliflozin Propanediol | 625 | 882 | 133 | $481K |
| Amiodarone Hcl Generic | 499 | 746 | 98 | $5,968 |
| Losartan Potassium Generic | 421 | 831 | 105 | $3,195 |
| Clopidogrel Clopidogrel Bisulfate | 368 | 777 | 82 | $2,721 |
| Amlodipine Besylate Generic | 331 | 667 | 74 | $1,497 |
| Hydrochlorothiazide Generic | 304 | 552 | 65 | $648 |
| Rosuvastatin Calcium Generic | 284 | 652 | 75 | $3,270 |
| Pravastatin Sodium Generic | 276 | 640 | 72 | $3,584 |
| Carvedilol Generic | 276 | 575 | 62 | $1,964 |
| Metoprolol Tartrate Generic | 270 | 485 | 55 | $980 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 238 | 449 | 44 | $2,227 |
Brand drugs: 3,338 claims; generic drugs: 8,290 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles S Lin $867 ($867 in general payments such as food, travel and fees) from 14 companies. The largest payer was Pfizer Inc. with $256.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 13 | $256 |
| Medtronic, Inc. MDT | 2 | $209 |
| Abiomed JNJ | 4 | $73.32 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $43.47 |
| Novo Nordisk Inc NVO | 2 | $42.76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35.84 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $31.44 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $31.23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $30.73 |
| Edwards Lifesciences Corporation EW | 1 | $27.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.